Senolytic ABT-263 Shows Promise in Mitigating Radiation-Induced Gastrointestinal Cancer
Recent studies at Georgetown University Medical Center have shown promising results regarding the use of the senolytic agent ABT-263 in mitigating the onset of gastrointestinal...